 GPB |
Glaxo Executives Cited in Case Now Lead Sanofi, Actelion
Businessweek Two senior executives at GlaxoSmithKline Plc (GSK) singled out by the U.S. Justice Department for pushing the Advair asthma drug for unapproved uses have moved on to some of Europe's top pharmaceutical companies. Glaxo Settlement Pulls Back Curtain On Drug Marketing |
View full post on asthma – Google News